Potential Mechanisms of Triptolide against Diabetic Cardiomyopathy Based on Network Pharmacology Analysis and Molecular Docking

Table 1

Pharmacological and molecular properties of triptolide.

Name	MW	AlogP	Hdon	Hacc	OB (%)	Caco-2	BBB	DL	FASA-	TPSA	RBN	HL
Triptolide	360.44	0.87	1	6	51.29	0.25	-0.19	0.68	0.28	84.12	1	4.14

Abbreviations: caco-2: caco-2 permeability; OB: oral bioavailability; Dl: drug likeness; BBB: blood–brain barrier.